Search

A recent study conducted by Northeast Agricultural University explores the potential of Dexmedetomidine in ameliorating acute kidney injury (AKI) by regulating mitochondrial dynamics through the a2-AR/SIRT1/PGC-1a pathway activation in rats. The research highlights the significance of Dexmedetomidine in reducing oxidative stress and apoptosis, protecting kidney structure and function, and modulating mitochondrial dynamics to provide nephroprotection in septic AKI. This study sheds light on a novel mechanistic molecular pathway for potential AKI treatment. [Extracted from the article]

A study conducted at Nanjing University of Chinese Medicine explores the role of M1 macrophage-derived exosomal miR-155 in enhancing autophagy in sepsis-triggered acute kidney injury (SA-AKI). The research suggests that targeting exosomal miR-155 could be a promising therapeutic strategy for SA-AKI. The study utilized a mouse model of SA-AKI and a sepsis cell model to investigate the relationship between M1 macrophage-derived exosomes and miR-155 in regulating autophagy during SA-AKI. [Extracted from the article]

A study conducted at Seth GS Medical College and KEM Hospital in Mumbai, India, focused on the development of acute kidney injury (AKI) following repair of Stanford type A aortic dissection (TAAD). The research found that AKI was associated with increased risks of mortality, stroke, dialysis, cardiovascular and respiratory complications, sepsis, and re-exploration for bleeding in patients undergoing TAAD repair. The study concluded that AKI significantly increases mortality, morbidity, hospital, and ICU stay duration in TAAD repair patients. [Extracted from the article]

Researchers from Technion-Israel Institute of Technology conducted a study on acute kidney injury, focusing on the potential nephroprotective effect of uPA against ischemia/reperfusion-induced AKI in aMUPA mice and HEK-293 cells. The study aimed to understand the pathogenesis of AKI and investigate therapeutic targets for renal damage treatment. Results showed that uPA modulates key pathways involved in AKI, offering potential therapeutic targets for mitigating renal damage. The research was funded by the Rabinovitz Research Fund-technion and published in Biomedicines. [Extracted from the article]

Researchers at the University of California San Francisco conducted a study on hydration strategies to prevent contrast-induced acute kidney injury in patients with chronic heart failure and chronic kidney disease. The study compared different hydration methods and found that the half-volume hydration regimen recommended by guidelines was associated with a higher incidence of kidney injury compared to standard hydration. However, combining standard hydration with a diuretic did not reduce the risk of heart failure or mortality during hydration, although it did not increase the risk of kidney injury. The study was published in the European Heart Journal. [Extracted from the article]

A study conducted by Bayer AG examined the association between a history of acute kidney injury (AKI) and major adverse cardiovascular events (MACE) in chronic kidney disease (CKD) patients. The study, which used electronic health records of over 54 million patients, found that CKD patients with a history of AKI were at a higher risk of adverse cardiovascular outcomes, particularly hospitalization for heart failure. The research suggests that these patients may benefit from cardio-protective interventions. The study was published in the European Heart Journal in 2024. [Extracted from the article]

A study conducted in Akron, Ohio, examined the sociodemographic disparities in 1-year outcomes of children with community-acquired acute kidney injury (CA-AKI). The research found that Black and Hispanic children had a lower survival probability compared to White children within 1 year of an initial emergency department encounter. Future studies are needed to address these disparities and enhance awareness and follow-up care after emergency treatment. The study analyzed data from 17,125 children, highlighting the importance of understanding and addressing racial and ethnic disparities in pediatric health outcomes. [Extracted from the article]

Researchers at Southern Medical University in Guangzhou, China, have conducted a study on the impact of chronic alcohol consumption on acute kidney injury (AKI). The study found that chronic alcohol consumption exacerbated AKI in female mice through integrin β1/JNK signaling, leading to increased kidney dysfunction and tubular cell apoptosis. The research suggests that alcohol consumption may increase vulnerability to AKI in female mice, potentially mediated by acetaldehyde/integrin β1/JNK signaling cascade. This study sheds light on the effects of alcohol abuse on kidney health and provides valuable insights for further research in this area. [Extracted from the article]

The article from Stem Cell Week discusses recent research from Memorial Sloan-Kettering Cancer Center on acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation. The study aimed to understand the relationship between gut microbiome diversity and kidney outcomes, but found no significant link between microbiome diversity and the development of kidney complications post-transplant. The research highlights the complex nature of acute kidney injury in transplant recipients and suggests the need for further studies in this area. [Extracted from the article]

The research article from Rutgers University New Jersey Medical School focuses on acute kidney injury (AKI) in hospitalized patients with cirrhosis. The study identifies predictors of AKI resolution and associated clinical outcomes, highlighting the importance of factors like albumin levels and cirrhosis etiology in determining resolution. The findings suggest that AKI resolution during hospitalization leads to improved short- and long-term transplant-free survival, emphasizing the need for aggressive management of AKI in high-risk patients to reduce mortality. The study's results provide valuable insights for clinicians in predicting AKI outcomes and improving patient care. [Extracted from the article]

A study conducted at Fuwai Hospital in Asia focused on validating the CA-AKI score in patients with acute coronary syndrome. The research aimed to predict the risk of contrast-associated acute kidney injury and its impact on short-term and long-term outcomes. The study found that the updated CA-AKI risk score accurately identified patients at risk for acute kidney injury, which was associated with higher rates of long-term mortality and bleeding. The findings were published in the European Heart Journal and can be accessed for further information. [Extracted from the article]

A recent study conducted by the University of Alberta in Canada focused on improving care for patients with acute kidney injury (AKI) after hospital discharge. The research implemented a risk-guided intervention to enhance adherence to recommended processes of care for chronic kidney disease (CKD) in high-risk patients. Results showed that the intervention group had higher rates of receiving treatment with angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin II receptor blockers (ARB), statins, and nephrology specialist follow-up compared to the usual care group. The study highlights the importance of tailored interventions to improve outcomes for AKI survivors in primary care settings. [Extracted from the article]

A recent study from Memphis, Tennessee, highlights the risks of fluid overload in critically ill children following hematopoietic cell transplant (HCT). The research emphasizes that fluid overload can lead to increased morbidity and mortality in these patients. Early detection, prevention, and intervention are crucial in managing fluid overload, with strategies including fluid restriction, diuretics, and continuous kidney replacement therapy (CKRT) when necessary. The study underscores the importance of identifying patients at risk of acute kidney injury (AKI) and fluid overload to improve outcomes in this vulnerable population. [Extracted from the article]

A recent study from the Department of Medical Education highlights the risk of acute kidney injury (AKI) following endovascular intervention for acute deep venous thrombosis. The research emphasizes the importance of early recognition and timely referral to nephrologists for patients at risk of AKI. The study specifically focuses on the use of AngioJet pharmacomechanical catheter-directed technique and its association with intravascular hemolysis leading to AKI. This research underscores the need for clinicians to be vigilant in monitoring and managing AKI in patients undergoing such procedures. [Extracted from the article]

A study conducted at Palacky University in Olomouc, Czech Republic, focused on acute kidney injury (AKI) caused by gentamicin nephrotoxicity. Gentamicin, an aminoglycoside antibiotic, is commonly used in treating bacterial infections but can lead to AKI. The research highlighted the potential of non-protein-coding RNAs, specifically microRNAs (miRNAs), as biomarkers for early detection and monitoring of AKI induced by gentamicin. This study underscores the importance of prompt diagnosis and effective management of AKI in patients receiving gentamicin therapy. [Extracted from the article]

A study conducted at Harbin Medical University in Heilongjiang, China, explored the role of S100A9 in sepsis-associated acute kidney injury (SA-AKI) through pyroptosis, a form of cell death. The research found that S100A9 plays a pivotal role in SA-AKI by activating the NLRP3 inflammasome and pyroptosis pathways. Clinical validation showed elevated S100A9 levels in SA-AKI patients, and experiments with S100A9 knockout mice demonstrated reduced kidney injury and inflammation. The study suggests that targeting S100A9 could be a potential therapeutic approach for improving outcomes in sepsis-related kidney injury patients. [Extracted from the article]

A study conducted at Wuhan University in China focused on the use of (+)-14,15-dehydrovincamine to mitigate cisplatin-induced acute kidney injury (AKI) by targeting the JNK/Mff pathway. The research highlighted the compound's ability to reduce mitochondrial fission, maintain mitochondrial homeostasis, and attenuate apoptosis in renal tubular epithelial cells. This study sheds light on potential therapeutic agents for AKI treatment and was supported by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. [Extracted from the article]

A study conducted at Southern Medical University in Guangzhou, People's Republic of China, focused on the impact of contrast-associated acute kidney injury (CA-AKI) on all-cause mortality in older patients after coronary angiography. The research found that CA-AKI was related to an increased risk of all-cause mortality during a 7.5-year follow-up period for patients aged over 75 years. This study highlights the significance of CA-AKI as an independent predictor of long-term mortality in older patients undergoing coronary angiography. [Extracted from the article]

A recent study conducted in Odisha, India, focused on the etiological spectrum of acute kidney injury (AKI) and its adverse outcomes. The research found that the incidence of AKI was 8.6%, with medical reasons being the most common cause, followed by obstetric and surgical reasons. The study highlighted the need for better preventive strategies, especially in the obstetric population, where AKI can lead to mortality or progression to chronic kidney disease. The findings underscore the importance of early detection and intervention in AKI cases. [Extracted from the article]

Researchers from Youjiang Medical University for Nationalities in China developed and validated a dynamic nomogram to predict short-term survival in patients with acute heart failure and acute kidney injury admitted to the ICU. The study analyzed data from 978 patients from 2008 to 2019 using the MIMIC-IV database. The nomogram incorporated factors like serum creatinine, race, age, and medication use to accurately predict patient outcomes. The research concluded that this nomogram could be a valuable tool for clinicians in predicting short-term prognosis for these patients. [Extracted from the article]

A study conducted at Vanderbilt University Medical Center explored the relationship between high-density lipoprotein (HDL) anti-inflammatory capacity and acute kidney injury (AKI) after cardiac and vascular surgery. The research found that patients with dysfunctional, pro-inflammatory HDL had a higher risk of postoperative AKI, while those with higher HDL anti-inflammatory capacity had a lower risk of AKI. Additionally, a higher long-term statin dose was associated with increased HDL anti-inflammatory capacity. The study highlights the importance of HDL function in reducing the risk of AKI in patients undergoing major surgeries. [Extracted from the article]

A recent report from Shanxi Medical University discusses the research advances in proteolysis targeting chimeras for acute kidney injury (AKI). AKI is a group of renal diseases characterized by a significant decline in renal function, with high mortality rates and potential progression to chronic kidney disease. The study highlights the potential of proteolysis targeting chimeras (PROTACs) as a novel strategy for AKI drug development through the degradation of target proteins. This research provides valuable insights into promising therapeutic targets for AKI and the application of PROTACs technology. [Extracted from the article]

Researchers from Children's Hospital Colorado conducted a retrospective analysis to investigate the risk of acute kidney injury (AKI) after lower urinary tract reconstruction with early NSAID therapy. The study aimed to determine if there was a difference in the incidence of postoperative AKI between patients who received NSAIDs and those who did not. The results showed no significant difference in the occurrence of AKI based on specific criteria, suggesting that postoperative NSAIDs were unlikely to be a source of AKI. However, AKI remained a risk following these surgeries, regardless of NSAID use, likely due to underlying disease, longer operations, and fluid shifts. [Extracted from the article]

Researchers at Kangwon National University in Gangwon Do, South Korea, conducted a retrospective analysis to identify factors associated with vancomycin-induced acute kidney injury (AKI). They found that high baseline serum creatinine levels, intensive care unit admission, and concurrent renal disorders were significantly linked to vancomycin-induced AKI. The study suggests that strategies to reduce the incidence of vancomycin-induced AKI should focus on underlying renal disease and intensive care unit admission rather than vancomycin pharmacokinetic parameters or dosage adjustments. Further prospective studies are needed to validate these findings. [Extracted from the article]

A study conducted at Shanxi University of Traditional Chinese Medicine examined the levels of SIRT6 and VNN1 in children with primary nephrotic syndrome to determine their correlation with acute kidney injury (AKI). The research involved 101 children diagnosed with PNS, with findings indicating that SIRT6 and VNN1 may serve as valuable biomarkers for diagnosing AKI in children with PNS. The study concluded that SIRT6 and VNN1 are closely associated with AKI in this population, highlighting their potential diagnostic significance. [Extracted from the article]

A recent study conducted at Medical College and Hospital explored the role of aminophylline in preventing acute kidney injury (AKI) in severely asphyxiated term neonates. The study involved administering a 5 mg/kg intravenous dose of aminophylline to neonates with severe asphyxia within the first hour after birth, in addition to standard care. While the study found that aminophylline treatment led to higher urine output in newborns, it did not significantly reduce the overall incidence of AKI. The findings suggest that a single dose of aminophylline may temporarily enhance urine output but does not prevent AKI in severely asphyxiated term neonates. [Extracted from the article]

Researchers from the First Affiliated Hospital of Guangxi Medical University conducted a study on the relationship between vitamin D deficiency and acute kidney injury (AKI) in patients with diabetes. The study found that low levels of 25-hydroxy-vitamin D (25(OH)D) were associated with an increased risk of AKI and dialysis in diabetic patients. Additionally, AKI patients with 25(OH)D deficiency had a higher risk of end-stage renal disease (ESRD) or all-cause death. This research highlights the importance of monitoring and addressing vitamin D levels in diabetic patients to prevent adverse kidney outcomes. [Extracted from the article]

Researchers from Shiraz University of Medical Sciences conducted a study to investigate acute kidney injury (AKI) induced by vancomycin, colistin, and liposomal amphotericin B in hospitalized patients. The study found that AKI occurred in 34.3% of patients, with dehydration and co-administration of nephrotoxic medications identified as significant risk factors. The research emphasizes the importance of addressing these factors in preventive strategies to reduce antibiotic-induced AKI in hospitalized patients. [Extracted from the article]

Researchers at the College of Medicine in Rochester, Minnesota, have published new data on the risk of acute kidney injury following exposure to intravenous iodinated contrast media. The study discusses the historical fears of nephrotoxicity associated with contrast material use and the evolving understanding of contrast-induced acute kidney injury. The research highlights the current state of knowledge on contrast-associated acute kidney injury, including risk factors, outcomes, and management strategies. This peer-reviewed study provides valuable insights into the complexities of kidney function and diagnostic radiology. [Extracted from the article]

Researchers from Universite Libre de Bruxelles have provided new insights into the hemodynamic management of acute kidney injury (AKI) in critically ill patients. The study discusses the role of interventions such as fluids, inotropes, and vasopressors in improving renal perfusion and function. While these interventions may enhance renal perfusion, their impact on renal function varies, highlighting the need for individualized management strategies. The study emphasizes the importance of monitoring renal perfusion through techniques like renal Doppler or contrast-enhanced ultrasound. [Extracted from the article]

A study conducted at the University of Kentucky examined the risk factors associated with acute kidney injury (AKI) following coronary artery bypass surgery. The research found that chronic lung disease and lower preoperative ejection fractions were linked to increased rates of AKI, while modifiable risk factors included perioperative blood transfusion and extended perfusion/cross-clamp times. Patients who developed AKI experienced longer ventilator times, hospital stays, and higher postoperative mortality rates. The study's findings suggest that addressing these risk factors may help reduce the incidence of AKI in patients undergoing coronary bypass surgery. [Extracted from the article]